C Brun-Buisson
Overview
Explore the profile of C Brun-Buisson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
3978
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mercat A, Pham T, Roze H, Cuquemelle E, Brun-Buisson C, Brochard L, et al.
Reanimation
. 2020 Apr;
20(3):162-168.
PMID: 32288724
The REVA-Flu-SRLF register allowed collection of data from 562 patients infected with H1N1 influenza virus 2009 and hospitalized in the intensive care unit (ICU). The overall mortality of these patients...
2.
Plantinga N, Wittekamp B, Brun-Buisson C, Bonten M
Clin Microbiol Infect
. 2019 Aug;
26(4):485-491.
PMID: 31421272
Objectives: The aim was to quantify the effects of selective digestive tract decontamination (SDD) consisting of a mouth paste and gastro-enteral suspension, selective oropharyngeal decontamination with a mouth paste (SOD)...
3.
Opatowski M, Tuppin P, Cosker K, Touat M, De Lagasnerie G, Guillemot D, et al.
Epidemiol Infect
. 2019 Mar;
147:e144.
PMID: 30869047
Massive use of antibiotics has led to increased bacterial resistance to these drugs, making infections more difficult to treat. Few studies have assessed the overall antimicrobial resistance (AMR) burden, and...
4.
Brun-Buisson C
Clin Microbiol Infect
. 2018 Jul;
24(11):1119-1120.
PMID: 30017968
No abstract available.
5.
Celeste C, Jolivet S, Bonneton M, Brun-Buisson C, Jansen C
Med Mal Infect
. 2017 Sep;
47(7):459-469.
PMID: 28943168
Objective: Guidelines have been issued in 2010 to prevent the spread of emerging extensively resistant bacteria (eXDR), but their implementation is difficult. We aimed to evaluate healthcare workers' (HCW) knowledge...
6.
Colomb-Cotinat M, Lacoste J, Brun-Buisson C, Jarlier V, Coignard B, Vaux S
Antimicrob Resist Infect Control
. 2016 Dec;
5:56.
PMID: 27999665
Background: A study based on 2007 data estimated that 386,000 infections due to multidrug-resistant bacteria (MDRB) occurred in Europe that year and 25,000 patients died from these infections. Our objective...
7.
Jolivet S, Fines-Guyon M, Nebbad B, Merle J, Le Pluart D, Brun-Buisson C, et al.
J Hosp Infect
. 2016 Oct;
94(4):346-350.
PMID: 27726900
Background: Vancomycin-resistant Enterococcus raffinosus has rarely been associated with nosocomial infection and outbreaks. Aim: To report the successful control of a nosocomial outbreak of vanA-type vancomycin-resistant E. raffinosus in a...
8.
Papo M, Valeyrie-Allanore L, Razazi K, Carteaux G, Wolkenstein P, Chosidow O, et al.
Br J Dermatol
. 2016 Aug;
176(5):1370-1372.
PMID: 27510226
No abstract available.
9.
Baraniak A, Izdebski R, Fiett J, Herda M, Derde L, Bonten M, et al.
Antimicrob Agents Chemother
. 2015 Dec;
60(3):1912-7.
PMID: 26711772
In a 2008-2011 survey, 17,945 patients in 18 hospital units in Europe and Israel were screened for carriage of Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae, resulting in identification of 124 positive...
10.
Maitre B, Djibre M, Katsahian S, Habibi A, Stankovic Stojanovic K, Khellaf M, et al.
Intensive Care Med
. 2015 Oct;
41(12):2121-9.
PMID: 26431718
Purpose: Previous clinical trials suggested that inhaled nitric oxide (iNO) could have beneficial effects in sickle cell disease (SCD) patients with acute chest syndrome (ACS). Methods: To determine whether iNO...